Mir-21-5p Promotes Lung Adenocarcinoma Progression Partially Through Targeting SET/TAF-Iα.

Jiacheng Zhong,Xiaohu Ren,Zhihong Chen,Hang Zhang,Li Zhou,Jianhui Yuan,Ping Li,Xiao Chen,Wei Liu,Desheng Wu,Xifei Yang,Jianjun Liu
DOI: https://doi.org/10.1016/j.lfs.2019.06.014
IF: 6.78
2019-01-01
Life Sciences
Abstract:Objective: Although SET(I2PP2A) and miRNAs are reported to play a pivotal role in lung cancer, the underlying mechanisms have remained obscure. To address this issue, we investigated how miRNAs and SET participate in the progression of lung cancer. Methods: miRNAs that target SET were predicted from multiple miRNA databases. Three human NSCLC cell lines and two normal lung cell lines were used to evaluate aberrant miRNA and SET expressions. A dual luciferase reporter assay system was employed to verify the interaction between miRNA and SET. Stable miRNA knockdown and SET overexpression in A549 cells were achieved through lentivirus transfection; the corresponding influences on lung cancer progression were also examined. Results: In this study, A549 was the sole cell line to lack SET/TAF-I alpha expression, which was inversely correlated with the up-regulation of miR-21-5p. SET was subsequently revealed as the direct target site of miR-21-5p in A549 cells. The stable miR-21-5p knockdown and SET/TAF-I alpha overexpression were shown to markedly enhance the expression of SET/TAF-I alpha and to inhibit the migration, invasion, proliferation as well as the in vivo tumorigenicity of A549 cells. Conclusion: We suggest that SET/TAF-I alpha might be a tumor suppressing factor regulated by miR-21-5p in lung adenocarcinoma. This might provide a target for lung adenocarcinoma therapy.
What problem does this paper attempt to address?